|
| |
Image Results
Loading...
Loading...
RENAGEL Pages on BioPortfolio:
|
BioPortfolio - GelTex Pharmaceuticals Incorporated
In October 1998, the Company received approval from the United States Food and Drug Administration (the "FDA") for its lead product Renagel(R)* Capsules ...
http://www.bioportfolio.com/biocorporate/4323-GelTex_Pharmac...
|
Biotechnology News RENVELA Search
8 Oct 2009 ... Shire's Fosrenol could have a clinical advantage over rival drug Renagel from Genzyme, according to the results of what is thought to be the ...
http://www.bioportfolio.co.uk/RENVELA-news.htm...
|
Shire Pharmaceuticals boosted by first Fosrenol approval
Fosrenol will nevertheless, face direct competition in the shape of Genzyme's Renagel, which generated around $160m in revenue in 2002, capturing a 40-45% ...
http://www.bioportfolio.com/news/datamonitor_59.htm...
|
BioPortfolio.com - BioWeb TIAZAC DILTIAZEM HYDROCHLORIDE Search
... 30-OCT-98 Trade Name: RENAGEL Chemical Type: 1 Therapeutic Potential: S Dosage Form: CAPSULE Applicant: GELTEX PHARMACEUTICALS INC Active Ingredient(s):
...
http://www.bioportfolio.co.uk/TIAZAC+DILTIAZEM+HYDROCHLORIDE...
|
BioPortfolio - Caro Research
Background: Sevelamer hydrochloride (Renagel) binds phosphate in patients... 24th July, 2008, Caro Research Institute, Concord, MA, USA (now United ...
http://www.bioportfolio.com/biocorporate/20494-Caro_Research...
|
BioPortfolio's Approved Drugs News by Tradename - Q to Sa
RENAGEL ...
http://www.bioportfolio.co.uk/approved_drugs/approved_drug_p...
|
BioPortfolio - GelTex Pharmaceuticals Incorporated - Profile
BACKGROUND: Clinical studies have shown sevelamer HCl (Renagel) to be...14th January, 2003. GelTex Pharmaceuticals, Waltham, Massachusetts, USA. ...
http://www.bioportfolio.com/biocorporate/4323-GelTex%2525252...
| Results from other life science and pharmaceutical sites:
Sevelamer - Wikipedia, the free encyclopedia
5 Aug 2009 ... phosphate and prevents its absorption. It is marketed by Genzyme under the trade names Renagel and Renvela (carbonate formulation). ...
http://en.wikipedia.org/wiki/Sevelamer...
|
Effect of RenaGel, a non-absorbed, calcium- and aluminium-free ...
The current study examined the efficacy of RenaGel, a calcium- and aluminium- free, polymeric phosphate binder, in end-stage renal disease patients. ...
http://www.ncbi.nlm.nih.gov/pubmed/9761513...
|
Kidney International - Abstract of article: RenaGel[reg], a ...
This multicenter, open-label, dose-titration study assessed the safety and efficacy of RenaGel®, a nonabsorbed calcium- and aluminum-free phosphate binder,
...
http://www.nature.com/ki/journal/v55/n1/abs/4490586a.html...
|
A randomized trial of sevelamer hydrochloride (RenaGel) with and ...
OBJECTIVE: We have previously shown sevelamer hydrochloride (RenaGel) to be an effective and well-tolerated treatment for hyperphosphatemia in hemodialysis ...
http://www.ncbi.nlm.nih.gov/pubmed/9988142...
|
Renagel in New Dialysis Study Published in Kidney International
Renagel in New Dialysis Study Published in Kidney International. Data Show That Patients Treated with Renagel Achieve Mortality Benefit .
http://www.prnewswire.com/news-releases/renagel-in-new-dialy...
|
Poly[allylamine hydrochloride] (RenaGel): a noncalcemic phosphate ...
RenaGel was found to be as effective as calcium carbonate or acetate as a phosphate binder. The reduction in serum phosphorus was significantly greater
...
http://www.ncbi.nlm.nih.gov/pubmed/9002531...
|
BioMed Central | Full text | RenaGel (Geltex Pharmaceuticals Inc)
RenaGel (Geltex Pharmaceuticals Inc) Appen K von IDrugs 1999 2:146-152. Access to the full text of this article requires a subscription. ...
http://www.biomedcentral.com/1369-7056/2/146...
|
Sevelamer hydrochloride (Renagel), a non-calcaemic phosphate ...
This study was conducted to examine whether sevelamer hydrochloride (Renagel); hereafter referred to as sevelamer), a non-calcaemic phosphate binder could ...
http://www.ncbi.nlm.nih.gov/pubmed/11522872...
|
{1} Release: Renagel Study In New Dialysis Patients Published In ...
29 Sep 2005 ... 29 /PRNewswire-FirstCall/ -- Genzyme Corporation announced today that results from the Renagel in New Dialysis (RIND) study have been ...
http://www.biospace.com/news_story.aspx?NewsEntityId=2130082...
|
Effect of RenaGel, a non-absorbable, cross-linked, polymeric ...
We have developed RenaGel, a novel, non-absorbed hydrogel which binds dietary phosphate leading to increased fecal excretion, decreased absorption and ...
http://www.ncbi.nlm.nih.gov/pubmed/9175050...
|
|
